Evidence map›Paper›PMID 36901874›Full record

ArticleInternational journal of molecular sciences2023

Renoprotective Impacts of

Kuang-Hsing Chiang, Yi-Chun Chiu, Noi Yar, Yu-Chun Chen, Chia-Hui Cheng, Yi-Chien Liu, Chia-Yu Chang, Jiunn-Jye Chuu

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. The Health and Clinical Benefits of Medicinal Fungi.Advances in biochemical engineering/biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kuang-Hsing ChiangTaipei Heart Institute, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0003-0376-9862
Yi-Chun ChiuDivision of Urology, Department of Surgery, Taipei City Hospital, Taipei 10341, Taiwan.
Noi YarTaipei Heart Institute, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-8879-0462
Yu-Chun ChenDepartment of Biotechnology and Food Technology, College of Engineering, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan.
Chia-Hui ChengDepartment of Biotechnology and Food Technology, College of Engineering, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan.
Yi-Chien LiuDepartment of Biotechnology and Food Technology, College of Engineering, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan.
Chia-Yu ChangDepartment of Neurology, Chi-Mei Medical Center, Tainan 71004, Taiwan.ORCID 0000-0002-3403-7165
Jiunn-Jye ChuuDepartment of Biotechnology and Food Technology, College of Engineering, Southern Taiwan University of Science and Technology, Tainan 71005, Taiwan.ORCID 0000-0003-1289-8412

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes nephropathy (DN) is one of the most common causes of end stage renal disease (ESRD) globally. Medication options to stop or slow the progression of chronic renal disease (CKD) are limited, and patients with DN remain at a high risk of developing renal failure.

Indexed as

Diabetes MellitusDiabetic NephropathiesAcetatesAnimalsInonotusKidneyMiceNephrectomyStreptozocinAcetatesethyl acetateStreptozocindiabetes nephropathyInonotus obliquusnephrectomystreptozotocinTGF-βα-SMA

Identifiers

PMID36901874
PMCPMC10002342

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read123
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.